Загрузка...
Lymphocyte‐activation gene‐3, an important immune checkpoint in cancer
Immunotherapy has recently become widely used in lung cancer. Many oncologists are focused on cytotoxic T lymphocyte antigen‐4 (CTLA‐4), programmed cell death ligand‐1 (PD‐L1) and programmed cell death‐1 (PD‐1). Immunotherapy targeting the PD‐1/PD‐L1 checkpoints has shown promising efficacy in non‐s...
Сохранить в:
| Опубликовано в: : | Cancer Sci |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5021038/ https://ncbi.nlm.nih.gov/pubmed/27297395 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12986 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|